Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Wolff

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Gastroenterology|August 1, 1995
Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's diseaseR S McLeod, B G Wolff, A H Steinhart, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1997
Locally advanced primary colorectal cancer: IOERT and EBRT +/-5-FUL L Gunderson, H Nelson, J A Martenson, et al.
Annals of Surgery|October 1, 1990
Ileal pouch-anal anastomosis. Reoperation for pouch-related complicationsS Galandiuk, N A Scott, R R Dozois, et al.
Journal of the American College of Surgeons|October 1, 1996
Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter studyJ M Becker, M T Dayton, V W Fazio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studiesA N Serafini, J L Klein, B G Wolff, et al.
Diseases of the Colon and Rectum|August 26, 1998
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter studyB G Wolff, J Bolton, R Baum, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2013
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel diseaseJ B Kisiel, T C Yab, F T Nazer Hussain, et al.
Gastroenterology|October 26, 2001
A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulasD A Schwartz, M J Wiersema, K M Dudiak, et al.
Gastroenterology|December 12, 1997
Risk and significance of endoscopic/radiological evidence of recurrent Crohn's diseaseR S McLeod, B G Wolff, A H Steinhart, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|June 24, 2023
Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, Toronto, Ont., September 6-9, 2007K M Devon, O Vergara, J C Victor, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Gastroenterology|August 1, 1995
Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's diseaseR S McLeod, B G Wolff, A H Steinhart, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1997
Locally advanced primary colorectal cancer: IOERT and EBRT +/-5-FUL L Gunderson, H Nelson, J A Martenson, et al.
Annals of Surgery|October 1, 1990
Ileal pouch-anal anastomosis. Reoperation for pouch-related complicationsS Galandiuk, N A Scott, R R Dozois, et al.
Journal of the American College of Surgeons|October 1, 1996
Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter studyJ M Becker, M T Dayton, V W Fazio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studiesA N Serafini, J L Klein, B G Wolff, et al.
Diseases of the Colon and Rectum|August 26, 1998
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter studyB G Wolff, J Bolton, R Baum, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2013
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel diseaseJ B Kisiel, T C Yab, F T Nazer Hussain, et al.
Gastroenterology|October 26, 2001
A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulasD A Schwartz, M J Wiersema, K M Dudiak, et al.
Gastroenterology|December 12, 1997
Risk and significance of endoscopic/radiological evidence of recurrent Crohn's diseaseR S McLeod, B G Wolff, A H Steinhart, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|June 24, 2023
Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, Toronto, Ont., September 6-9, 2007K M Devon, O Vergara, J C Victor, et al.
Pageof 13